Teva enrolls patients for Phase III multiple sclerosis trial
Trading Markets (press release) - Los Angeles,CA,USA
Bravo is a global, 24-month, double-blind study designed to evaluate the efficacy, safety and tolerability of the oral compound laquinimod versus placebo, ...
See all stories on this topic

 

Teva Pharma announces enrolment of patients for BRAVO Phase III ...
RTT News - Williamsville,NY,USA
Teva Pharma noted that a second global Phase III trial of laquinimod, including thousand patients ALLEGRO, is also ongoing and recruiting patients worldwide ...
See all stories on this topic

 

Teva, Active Biotech enroll patients in second MS-drug trial
MarketWatch - USA
By Robert Daniel , , ) the Lund, Sweden, biotechnology company, said they're enrolling patients in a second Phase III trial of laquinimod, a treatment taken ...
See all stories on this topic

 

Teva enrols patients for large phase-three study
Hays Pharma - London,Greater London,UK
Active Biotech and Teva have announced they are enrolling patients on to a pivotal phase-three trial of the oral compound laquinimod. ...
See all stories on this topic

 

TEVA ENROLLS PATIENTS FOR A SECOND LARGE GLOBAL PHASE III TRIAL OF ...
Ad-Hoc-News (Pressemitteilung) - Germany
Projects in pivotal phase are laquinimod, anorally administered small molecule with unique immunomodulatoryproperties for the treatment of multiple ...
See all stories on this topic

 

Teva Enrolls Patients for a Second Large Global Phase III Trial of ...
WELT ONLINE - Germany
BRAVO is a global, 24-month, double-blind study designed to evaluate the efficacy, safety and tolerability of the oral compound laquinimod versus placebo, ...
See all stories on this topic

 

TEVA ENROLLS PATIENTS FOR A SECOND LARGE GLOBAL PHASE III TRIAL OF ...
MarketWatch - USA
Projects in pivotal phase are laquinimod, an orally administered small molecule with unique immunomodulatory properties for the treatment of multiple ...
See all stories on this topic

---

Teva faces trouble over Copaxone
Trading Markets (press release) - Los Angeles,CA,USA
Jul 16, 2008 (Datamonitor via COMTEX) -- TEVA | Quote | Chart | News | PowerRating -- Israeli generics company Teva Pharmaceutical Industries is reportedly ...
See all stories on this topic

 

Teva starts second Phase III trial of oral MS drug, plans Barr bid?
Pharma Times (subscription) - London,UK
The firms noted that patients are being enrolled for BRAVO, a Phase III 24-month, double-blind study designed to evaluate laquinimod versus placebo, ...
See all stories on this topic

---

 

PTC inks $437M pact with Genzyme
FierceBiotech - Washington,DC,USA
ALSO: Xconomy examines Genzyme's late-stage MS drug Campath, which could go head to head against Biogen Idec's Avonex and Tysabri for the ...
See all stories on this topic

Genzyme Reaching For a Slice From Biogen’s Breadbasket, Multiple ...
Xconomy - Cambridge,MA,USA
Like Biogen’s Tysabri, Campath is an engineered antibody, but it hits a different target on immune cells than Tysabri does. Campath was approved for ...
See all stories on this topic

---

 

Latest News, Developments and Drug Pipelines for Central Nervous ...
MarketWatch - USA
"Central Nervous System Multiple Sclerosis" contains detailed information on the current drug pipeline. This report provides insight into the pipeline ...
See all stories on this topic

 

Man jailed over 'monster-truck' crash
East Anglian Daily Times - Ipswich,England,UK
Row's father died in January and his mother was struck down with multiple sclerosis. The court heard how he had concerns for his mother who was due to have ...
See all stories on this topic

 

Marijuana’s tangled roots run through society
Vernon County Broadcaster - Viroqua,WI,USA
... can create appetite stimulation for AIDS and cancer patients; nausea control for cancer patients; muscle relaxation for multiple sclerosis patients; ...
See all stories on this topic

---

FTY720

 

Novartis gains momentum with strong performance in first half of ...
Ad-Hoc-News (Pressemitteilung) - Germany
Priority areas included oncology compoundssuch as Afinitor, further support for Cardiovascular products andemerging late-stage compounds such as FTY720. ...
See all stories on this topic

 

Novartis Posts 12% Rise in Net
Wall Street Journal - USA
... saying plans to submit its experimental cancer drug everolimus for regulatory approval in the second half, and multiple-sclerosis pill FTY720 in 2009. ...
See all stories on this topic

 

Novartis Gains Momentum With Strong Performance In First Half Of ...
ABN Newswire (press release) - Sydney,NSW,Australia
Priority areas included oncology compounds such as Afinitor, further support for Cardiovascular products and emerging late-stage compounds such as FTY720. ...
See all stories on this topic

 

---

 

http://www.msanswers.ca/QuestionView.aspx?L=2&QID=1987

Dr. Rodgers

Cinical psychologist at the University of Alberta Hospital

View BIO

Q :
My husband was recently diagnosed with MS. He has never dealt with "stress" very effectively; now it is so much worse. We feel as though we have to walk on eggshells around him, and that is hard, as we have young children. He even makes comments such as "You better be good, I'll be dead soon." This is heartbreaking to us, and he just doesn't see that. Any advice to help him see? I know he is the one we have to be worried about, but he could have very little disability, and we are missing out on life so much already with this attitude.
A :
Initial responses to a diagnosis of chronic illness have a lot to do with an individual’s personality and past experience. If your husband has never dealt with stress effectively, it is not surprising that he is greatly challenged by the recent diagnosis. Unfortunately, it is often loved ones who bear the brunt of anger, frustration, and sadness of the person who is responding to his or her own fears of an unknown future.
Some times it takes a professional or someone who is not personally involved to provide the education, counseling, and help that are needed. The MS Society is a good place to start. They might have support groups, peer counseling or a list of counselors/psychologists who understand the psychological impact of MS on individuals and family members.
It is important that you support your husband in any way that you can and be flexible and forgiving during this time. However, it is important that he take responsibility for his behavior and appreciate the impact it is having on the children. Encourage him to share his thoughts and feelings with you. The sooner he starts to talk about his fears and concerns the better it will be for the entire family.
If your husband does not respond to either of these requests, it is time for you to be more assertive. Assertiveness means being able to tell him in a non critical way what the family needs from him and in turn, what he wants from the family in order to cope and make healthy adjustments. If you feel unsure of how to be assertive, you might benefit from support and help on how to open lines of communication.
Until your husband is ready to ask for help, your options are limited. This is a very difficult time for him but equally difficult for you in a different way. While his behavior is not uncommon, it is unhealthy for the family if it continues.
7/18/2008 2:28:25 AM
More answers from Dr. Jennifer Rodgers
More answers in the category: Family Issues

---

Memorial Books
Leader Times - Kittanning,PA,USA
Rosella R. Ritchey from Stitt's Auto Sales: "Multiple Sclerosis - A New Journey" by Richard C. Senelick, MD Joseph Rivi from Mrs. Elsie Kalmar: "The Other" ...
See all stories on this topic

 

---

Accelerated Cure Project
Genetic researchers in Syracuse, NY have identified gene variants
  that may affect severity of MS. They were trying to confirm previous
  findings that linked genes in the CCL cluster on chromosome 17 with
  a higher risk of MS, but those results couldn't be
  replicated. However, when they analyzed the data for severity, they
  found variants in the CCL8 gene that were more frequent in subjects
  with "severe" MS compared with subjects with "mild" MS. CCL genes
  play a role in the immune response, so these results suggest that
  factors that influence immune responses may also influence the
  severity of MS.
  This study is of particular interest to us at Accelerated Cure
  Project because the samples used included DNA samples from our
  sample and data repository. In fact, this is the first published
  journal article that mentions our repository as a source of
  samples. We expect there will be many more!
http://tinyurl.com/5878tp

---

Complementary Medicine / Alternative Medicine News

Therapeutic Lifestyle Change (TLC) Programs: The Key To Fighting Chronic Disease
Chronic diseases such as type 2 diabetes and heart disease have reached epidemic proportions, affecting half of Americans and costing $1.5 trillion annually. But a little-known and relatively inexpensive tool called a TLC program has been shown to be effective in preventing, managing, or even reversing, many of our most prevalent chronic conditions.

A Shortcut For Communication Between Brain Cells - Understanding How Neurons Communicate May Help Treat Brain Disorders
For the first time, Weill Cornell scientists have learned important details illustrating how neuronal cells in the brain communicate at a microcellular level. Such knowledge may help in the development of drug compounds used to treat disorders caused by malfunctions in communication between brain cells, such as schizophrenia, epilepsy, Parkinson's and Alzheimer's disease.

Vitamin D can Do Much More Apart from Building Bones
TamilStar.com - Sri Lanka
Vitamin D is essential to strong bones. Inadequate vitamin D can lead to osteoporosis, a brittle bone disease. Recently, researchers have found that vitamin ...
See all stories on this topic

Healthy Travel Media Launches Second Edition of Patients Beyond ...
MarketWatch - USA
Patients Beyond Borders has helped thousands travel abroad successfully for medical care, and the Second Edition now offers patients even greater choice. ...
See all stories on this topic